246
Views
8
CrossRef citations to date
0
Altmetric
Articles

Clinical features of axial undifferentiated spondyloarthritis (USpA) in China: HLA-B27 is more useful for classification than MRI of the sacroiliac joint

, , , , , , , , , & show all
Pages 439-443 | Accepted 29 Apr 2011, Published online: 04 Jul 2011

References

  • Hanova P, Pavelka K, Holcatova I, Pikhart H. Incidence and preva- lence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol 2010;39:310–17.
  • Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991;34:1218–27.
  • Rudwaleit M, Haibel H, Baraliakos X, Listing J, Marker-Hermann E, Zeidler H, The early disease stage in axial spondyloarthritis results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717–27.
  • Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68;777–83.
  • Rudwaleit M, Jurik AG, Hermann KG, Landewé R, van der Heijde D, Baraliakos X, Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009;68;1520–7.
  • Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthropathies early. Ann Rheum Dis 2004;63:535–43.
  • Liao ZT, Gu JR, Huang F, Lin ZM, Zhao LK, Yu BY. Verification of Berlin algorithm for diagnosing undifferentiated spondyloarthropathy patients in Chinese population. Joint Bone Spine 2009;76:146–9.
  • Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58–67.
  • Feldtkeller E, Khan MA, van der Heijer D, van der Linder S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs positive patients with ankylosing spondylitis. Rheumatol Int 2003; 23:61–6.
  • Marzo-Ortega H, McGonagle D, O'Connor P, Hensor EMA, Bennett AN, Green MJ, Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 2009;68:1721–7.
  • Bennett AN, McGonagle D, O'Connor P, Hensor EM, Sivera F, Coates LC, Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008; 58:3413–18.
  • Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. MRI in predicting a major clinical response to antitumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008;67:1276–81.
  • Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68;770–6.
  • Lambert RGW, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis. Arthritis Rheum 2007;56:4005–14.
  • Jarrett SJ, Sivera F, Cawkwell LS, Marzo-Ortega H, McGonagle D, Hensor E, MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. Ann Rheum Dis 2009;68:1466–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.